Instituto de Patologia y Biologia Molecular Arias Stella
The Peru-based Instituto de Patologia y Biologia Molecular Arias Stella operates under the Unilabs brand, providing anatomical pathology and genetics/molecular biology diagnostic services to healthcare professionals and patients as part of the multinational Unilabs network.
- Company typePrivate
- Founded-
- HeadquartersJesús María, Peru
- Headcount11–50
- GTM typeB2B and B2C
- OfferingServices
What Instituto de Patologia y Biologia Molecular Arias Stella does
Instituto de Patologia y Biologia Molecular Arias Stella is a Peru-based clinical diagnostics laboratory operating under the Unilabs brand. Its core service offering is diagnostic support in two disciplines: Anatomía Patológica (Anatomical Pathology) and Genética y Biología Molecular (Genetics and Molecular Biology). Both are positioned on the unilabs.pe site as the institute's principal diagnostic capabilities for healthcare professionals, with a parallel patient-facing channel ("pacientes") that enables direct patient access to testing services.
Operationally, the institute is the Peruvian node of the broader Unilabs multinational diagnostic network, which maintains country-specific websites and operating units across Europe (Czech Republic, Denmark, Finland, France, Netherlands, Norway, Portugal, Slovakia, Spain, Sweden, Switzerland, United Kingdom), the Middle East (UAE), and Latin America (Peru). Within Peru, the institute is supported by a facility locator (centros.unilabs.pe), a publicly disclosed Política de Calidad (quality policy), a corporate data-protection policy, and a Libro de Reclamaciones channel—standard governance markers for a regulated clinical laboratory.
The business model is service-based B2B/B2C diagnostic testing: healthcare professionals refer specimens (tissue, fluid, blood) for pathological and molecular analysis, while patients can also access testing directly. Revenue mechanics, pricing, customer concentration, and unit volumes are not disclosed in the available data; only the legal name (Instituto de Patologia y Biologia Molecular Arias Stella), its Peru domicile, and its operation as part of the Unilabs network are confirmed.
Instituto de Patologia y Biologia Molecular Arias Stella firmographics
Firmographics- Name
- Instituto de Patologia y Biologia Molecular Arias Stella
- Legal name
- Instituto de Patologia y Biologia Molecular Arias Stella
- Website
- https://ariasstella.com
- Company type
- Private
- Operating status
- Operating
- Headcount range
- 11–50 employees
- Short description
- The Peru-based Instituto de Patologia y Biologia Molecular Arias Stella operates under the Unilabs brand, providing anatomical pathology and genetics/molecular biology diagnostic services to healthcare professionals and patients as part of the multinational Unilabs network.
- Ownership category
- akta.pro rank
Where Instituto de Patologia y Biologia Molecular Arias Stella is headquartered
LocationHeadquarters
- HQ city
- Jesús María
- HQ country
- Peru
- HQ region
- Latin America
Markets served
Instituto de Patologia y Biologia Molecular Arias Stella business model
Business model- GTM type
- B2B and B2C
- Offering type
- Services
- Cost components
- Personnel, Operations, Technology or R&D, Infrastructure
Instituto de Patologia y Biologia Molecular Arias Stella product offering
Product offeringCore offering
The institute provides diagnostic support services focused on Anatomical Pathology and Genetics and Molecular Biology, delivering specialized laboratory testing and pathology interpretation to healthcare professionals and patients in Peru. Operations are conducted under the Unilabs brand as part of a multinational diagnostic network spanning Europe, the Middle East, and Latin America.
Product overview
Unilabs offers diagnostic support services primarily in Anatomía Patológica (Anatomical Pathology) and Genética y Biología Molecular (Genetics and Molecular Biology) for healthcare professionals and patients. The company operates as part of a multinational network with country-specific websites across Europe, Middle East, and Latin America. The Peru operations focus on delivering pathology and molecular biology diagnostic services to patients and healthcare professionals.
Differentiator
Problem solved
Functional benefit
Products and services
- Anatomía Patológica (Anatomical Pathology) Diagnostic support service in anatomical pathology providing tissue analysis and pathological interpretation for healthcare professionals and patients.
- Genética y Biología Molecular (Genetics and Molecular Biology) Diagnostic service in genetics and molecular biology offering specialized molecular-level testing and analysis for healthcare professionals and patients.
Companies that use Instituto de Patologia y Biologia Molecular Arias Stella
Customer profileIdeal customer profiles2 records
Instituto de Patologia y Biologia Molecular Arias Stella technology and API
TechnologyTechnology focussed No
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Instituto de Patologia y Biologia Molecular Arias Stella partnerships and signals
Strategic signalRecent moves3 records
Expansion highlights3 records
Instituto de Patologia y Biologia Molecular Arias Stella competitors and assessment
Company assessmentDirect peers
- BioReference Laboratories: BioReference Laboratories is a US-focused specialty clinical laboratory offering pathology, genetics, and molecular diagnostics. Comparable as a specialty peer with overlapping expertise in anatomic pathology and molecular biology testing for healthcare professionals.
- Synlab: Synlab is the largest European clinical diagnostics and pathology network and Unilabs' closest direct competitor. Comparable as a multinational medical laboratory operator offering anatomical pathology, genetics, and molecular biology services to healthcare professionals across multiple geographies.
Others
- Roche Diagnostics: Roche Diagnostics is a leading global provider of molecular diagnostics platforms, reagents, and companion diagnostics used by pathology and molecular biology labs. Comparable as an enabling ecosystem participant whose technology underpins molecular biology testing at labs like Arias Stella.
Broad incumbents
- Unilabs: Unilabs is the parent multinational diagnostic network under which Instituto de Patologia y Biologia Molecular Arias Stella operates as the Peru entity. Directly comparable as the broader pathology and molecular diagnostics platform spanning Europe, Middle East, and LATAM.
- Eurofins Scientific: Eurofins is a global testing services group with substantial clinical diagnostics and specialty pathology operations across Europe and LATAM. Comparable as a broad incumbent offering medical and diagnostic laboratory testing at scale.
- Laboratory Corporation of America (Labcorp): Labcorp Diagnostics operates a global clinical laboratory business with significant specialty testing, pathology, and esoteric molecular diagnostics offerings. Comparable as a broad incumbent in medical and diagnostic laboratory services serving healthcare providers.
- Quest Diagnostics: Quest Diagnostics is one of the world's largest clinical laboratory networks, with deep specialty testing, anatomical pathology, and molecular diagnostics capabilities. Comparable as a broad incumbent offering the same diagnostic service categories to physicians and hospitals.
Regional players
- Hospital Italiano de Buenos Aires - Departamento de Anatomía Patológica: Hospital Italiano de Buenos Aires operates a renowned anatomical pathology and molecular diagnostics service within a leading academic hospital in Argentina. Comparable as a regional LATAM peer offering specialty pathology and molecular biology services to physicians and patients.
Market position
Strengths4 records
Weaknesses4 records
Competitive moat3 records
Key highlights5 records
Customer concentration
Instituto de Patologia y Biologia Molecular Arias Stella social profiles
Digital presenceInstituto de Patologia y Biologia Molecular Arias Stella financial estimates
Financial estimateRevenue estimate
Valuation estimate
Instituto de Patologia y Biologia Molecular Arias Stella leadership team
Management profileNumber of profiles
Instituto de Patologia y Biologia Molecular Arias Stella funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
Instituto de Patologia y Biologia Molecular Arias Stella M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about Instituto de Patologia y Biologia Molecular Arias Stella
What does Instituto de Patologia y Biologia Molecular Arias Stella do?
The institute provides diagnostic support services focused on Anatomical Pathology and Genetics and Molecular Biology, delivering specialized laboratory testing and pathology interpretation to healthcare professionals and patients in Peru. Operations are conducted under the Unilabs brand as part of a multinational diagnostic network spanning Europe, the Middle East, and Latin America.
When was Instituto de Patologia y Biologia Molecular Arias Stella founded?
Instituto de Patologia y Biologia Molecular Arias Stella was founded in -1. It employs 11 to 50 people.
Where is Instituto de Patologia y Biologia Molecular Arias Stella based?
Instituto de Patologia y Biologia Molecular Arias Stella is headquartered in Jesús María, Peru, in the Latin America region.
Who are Instituto de Patologia y Biologia Molecular Arias Stella's main competitors?
Direct peers on record are BioReference Laboratories and Synlab. Roche Diagnostics is listed as an others. Broad incumbents are Unilabs, Eurofins Scientific, Laboratory Corporation of America (Labcorp) and Quest Diagnostics. Hospital Italiano de Buenos Aires - Departamento de Anatomía Patológica is listed as a regional player.
Does Instituto de Patologia y Biologia Molecular Arias Stella have an API?
No public API is recorded for Instituto de Patologia y Biologia Molecular Arias Stella.